Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Benztropine mesylate
Drug ID BADD_D00245
Description Benztropine, with the chemical formula 3alpha-diphenylmethoxytropane, is a tropane-based dopamine inhibitor used for the symptomatic treatment of Parkinson's disease. It is a combination molecule between a tropane ring, similar to cocaine, and a diphenyl ether from the dialkylpiperazines determined to be a dopamine uptake inhibitor since 1970. The generation of structure-activity relationships proved that benztropine derivatives with the presence of a chlorine substituent in the para position in one of the phenyl rings produces an increased potency for dopamine uptake inhibition as well as a decreased inhibition of serotonin and norepinephrine.[A37914] Benztropine was developed by USL Pharma and officially approved by the FDA on 1996.[L5500]
Indications and Usage For use as an adjunct in the therapy of all forms of parkinsonism and also for use in the control of extrapyramidal disorders due to neuroleptic drugs.
Marketing Status Prescription; Discontinued
ATC Code N04AC01
DrugBank ID DB00245
KEGG ID D00778
MeSH ID D001590
PubChem ID 3246155
TTD Drug ID D0HQ6N
NDC Product Code 76385-104; 76385-105; 62135-142; 63629-2132; 70518-2677; 64181-0088; 0832-1082; 0603-2434; 0904-6789; 0615-8210; 49452-1016; 70518-1688; 76339-138; 0615-8211; 70518-0881; 50090-3883; 30007-817; 0603-2433; 70518-1709; 0143-9233; 68475-512; 60687-379; 62135-144; 0603-2438; 63323-970; 70518-1691; 43353-707; 48954-448; 70518-1447; 58118-0043; 63629-2133; 60687-368; 0904-6790; 69315-137; 70518-0577; 63629-2135; 72166-005; 68382-860; 50090-4082; 63187-840; 70518-0720; 0143-9729; 43353-580; 50090-3882; 0603-2439; 69315-138; 0832-1080; 71610-502; 60687-356; 0904-6788; 0832-1081; 70518-2732; 0603-2437; 69315-136; 50090-3116; 63629-2134; 55154-8095; 0615-8352; 71335-0665; 76385-103; 61919-128; 0603-2435; 66064-1023
Synonyms Benztropine | Benzatropine | Bensylate | Benzatropine Methanesulfonate | Methanesulfonate, Benzatropine | Benzatropine Mesylate | Mesylate, Benzatropine | Benztropine Mesylate | Mesylate, Benztropine | Benzatropine Methanesulfonate, Hydrobromide | Hydrobromide Benzatropine Methanesulfonate | Methanesulfonate, Hydrobromide Benzatropine | PMS-Benztropine | PMS Benztropine | Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer | Cogentin | Cogentinol | N-Methylbenztropine | N Methylbenztropine | Apo-Benztropine | Apo Benztropine | Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer
Chemical Information
Molecular Formula C22H29NO4S
CAS Registry Number 132-17-2
SMILES CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Depression19.15.01.001--
Disorientation19.13.01.002; 17.02.05.015--Not Available
Dry mouth07.06.01.002--
Dysuria20.02.02.002--
Hallucination, visual19.10.02.004--Not Available
Heat stroke24.06.02.009; 12.05.01.001--Not Available
Hyperthermia12.05.01.002; 08.05.01.001--Not Available
Hypoaesthesia17.02.06.023--Not Available
Ileus paralytic07.02.05.001--Not Available
Listless19.04.04.003; 08.01.01.012--Not Available
Memory impairment19.20.01.003; 17.03.02.003--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Tachycardia02.03.02.007--Not Available
Urinary retention20.02.02.011--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Decreased appetite14.03.01.005; 08.01.09.028--
The 1th Page    1    Total 1 Pages